Myriad Genetics | MYGN - Sales Revenues



Myriad Genetics reported $213.1M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Agilent USD 1.74B 68M Jul/2025
Becton, Dickinson and Co. USD 5.5B 230M Jun/2025
Bio-Rad Laboratories USD 651.6M 66.2M Jun/2025
Bruker USD 797.4M 4M Jun/2025
Danaher USD 5.94B 200M Jun/2025
Exact Sciences USD 811.1M 104.1M Jun/2025
Hologic USD 1.02B 10M Jun/2025
Illumina USD 1.06B 20M Jun/2025
J&J USD 23.74B 1.85B Jun/2025
Mettler Toledo International USD 983.22M 99.48M Jun/2025
Myriad Genetics USD 213.1M 17.2M Jun/2025
Quest Diagnostics USD 2.76B 110M Jun/2025
Quidel USD 614M 79M Jun/2025
Repligen USD 182M 13M Jun/2025
Revvity USD 720M 55M Jun/2025
Standard Biotools USD 21.76M 24.96M Jun/2025
Thermo Fisher Scientific USD 10.85B 490M Jun/2025
Veracyte USD 130.16M 15.69M Jun/2025
Waters USD 771M 109M Jun/2025